Our February newsletter features resources about antibiotics for uncomplicated UTI, Māori experiences of care for minor ailments, and ACE inhibitor changes.
From The Team
Our January newsletter outlines what you can expect from us this year. This includes two podcasts on antimicrobial stewardship, an equity webinar, a 'viral prescription' form, and a quality improvement planning template.
It's been a huge year for us, and we've been so grateful for your support. In our December newsletter we revisit our most popular resources from the year, outline what you can expect from us in 2023, and provide you with updates from our sector relationship manager.
Our November newsletter focuses on the launch of our antimicrobial content including an article on antimicrobial resistance and the new EPiC Antibiotics dashboard.
This page provides the specific methodology used for each data story featured in EPiC Antibiotics.
Our October newsletter features EPiC updates and training, Evusheld, new brand changes and more.
Our August newsletter is all about asthma, coinciding with the Asthma + Respiratory Foundation (ARFNZ) Breathe Better September campaign. We highlight the new EPiC Asthma dashboard, our asthma resource hub, bulletin #17, and asthma courses available through ARFNZ and Asthma NZ.
This page provides the specific methodology used for each data story featured in EPiC Asthma.
Our August newsletter features new asthma content, including an article on the changes to recommended asthma management and a free webinar. You'll also find links to the EPiC data club, an EPiC Cilazapril update, and the latest bulletin.
A consultant general practitioner from Botany Junction Medical is the winner of a $2000 travel voucher after logging into the new He Ako Hiringa EPiC dashboard. Click here to read more.
Our July newsletter is EPiC! Explore our new EPiC user guide, apply for an EPiC practice account, and register for the EPiC data club. We also feature our Accuretic article and bulletin #15.
Our June newsletter features the new EPiC CVD dashboard, a Q&A list about the adalimumab funding changes, a bulletin on health managers and equity, and our new Focus magazine.